Effects of edrophonium on saccadic velocity in normal subjects and myasthenic and nonmyasthenic ocular palsies.

We measured saccadic peak velocities in 8 patients with myasthenia gravis, 9 patients with proven nonmyasthenic ocular palsies, and 3 controls. Patients followed a target moving to and from primary position at 1-second intervals for 8 minutes. We measured the amplitudes and velocities of centrifugal saccades at the start of the task, after 3 minutes of the task (fatigue) and 1 minute after receiving IV edrophonium. The effects of fatigue, though prominent in some myasthenic patients, did not distinguish between the groups. However, edrophonium increased saccadic peak velocities in myasthenic patients but decreased them in both controls and nonmyasthenic patients. Analysis of saccades by amplitude bins showed that these changes in peak velocity reflected shifts in the velocity-amplitude relationship.
AuthorsJ J Barton, A G Huaman, J A Sharpe
JournalAnnals of neurology (Ann Neurol) Vol. 36 Issue 4 Pg. 585-94 (Oct 1994) ISSN: 0364-5134 [Print] UNITED STATES
PMID7944291 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Edrophonium
  • Adult
  • Aged
  • Edrophonium (pharmacology)
  • Humans
  • Middle Aged
  • Myasthenia Gravis (physiopathology)
  • Ophthalmoplegia (physiopathology)
  • Saccades (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: